Newborn Screening Market Size, Share & Trends Report

Newborn Screening Market Size, Share & Trends Analysis Report By Technology (Tandem Mass Spectrometry, Pulse Oximetry), By Type of Test (Dry Blood Spot Test, CCHD), And Segment Forecasts, 2012 - 2022

  • Report ID: 978-1-68038-490-1
  • Number of Pages: 95
  • Format: Electronic (PDF)
  • Historical Range: 2012 - 2015
  • Industry: Healthcare

Market segmentation

  • Global Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
    • Instruments
    • Reagents & Assay Kits
  • Global Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
    • Tandem Mass Spectrometry
    • Pulse Oximetry
    • Enzyme Based Assays
    • DNA Assays
    • Electrophoresis
  • Global Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
    • Dry Blood Spot Test
    • Critical Congenital Heart Disease (CCHD)
    • Hearing Screen
  • Newborn Screening Regional Outlook (Revenue, USD Million, 2012 - 2022)
    • North America
      • The U.S.
        • The U.S. Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
          • Instruments
          • Reagents & Assay Kits
        • The U.S. Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
          • Tandem Mass Spectrometry
          • Pulse Oximetry
          • Enzyme Based Assays
          • DNA Assays
          • Electrophoresis
        • The U.S. Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
          • Dry Blood Spot Test
          • Critical Congenital Heart Disease (CCHD)
          • Hearing Screen
      • Canada
        • Canada Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
          • Instruments
          • Reagents & Assay Kits
        • Canada Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
          • Tandem Mass Spectrometry
          • Pulse Oximetry
          • Enzyme Based Assays
          • DNA Assays
          • Electrophoresis
        • Canada Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
          • Dry Blood Spot Test
          • Critical Congenital Heart Disease (CCHD)
          • Hearing Screen
    • Europe
      •  The U.K.
        • The U.K. Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
          • Instruments
          • Reagents & Assay Kits
        • The U.K. Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
          • Tandem Mass Spectrometry
          • Pulse Oximetry
          • Enzyme Based Assays
          • DNA Assays
          • Electrophoresis
        • The U.K. Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
          • Dry Blood Spot Test
          • Critical Congenital Heart Disease (CCHD)
          • Hearing Screen
      •  Germany
        • Germany Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
          • Instruments
          • Reagents & Assay Kits
        • Germany Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
          • Tandem Mass Spectrometry
          • Pulse Oximetry
          • Enzyme Based Assays
          • DNA Assays
          • Electrophoresis
        • Germany Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
          • Dry Blood Spot Test
          • Critical Congenital Heart Disease (CCHD)
          • Hearing Screen
      •  France
        • France Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
          • Instruments
          • Reagents & Assay Kits
        • France Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
          • Tandem Mass Spectrometry
          • Pulse Oximetry
          • Enzyme Based Assays
          • DNA Assays
          • Electrophoresis
        • France Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
          • Dry Blood Spot Test
          • Critical Congenital Heart Disease (CCHD)
          • Hearing Screen
    • Asia Pacific
      •  Japan
        • Japan Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
          • Instruments
          • Reagents & Assay Kits
        • Japan Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
          • Tandem Mass Spectrometry
          • Pulse Oximetry
          • Enzyme Based Assays
          • DNA Assays
          • Electrophoresis
        • Japan Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
          • Dry Blood Spot Test
          • Critical Congenital Heart Disease (CCHD)
          • Hearing Screen
      •  China
        • China Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
          • Instruments
          • Reagents & Assay Kits
        • China Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
          • Tandem Mass Spectrometry
          • Pulse Oximetry
          • Enzyme Based Assays
          • DNA Assays
          • Electrophoresis
        • China Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
          • Dry Blood Spot Test
          • Critical Congenital Heart Disease (CCHD)
          • Hearing Screen
      •  India
        • India Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
          • Instruments
          • Reagents & Assay Kits
        • India Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
          • Tandem Mass Spectrometry
          • Pulse Oximetry
          • Enzyme Based Assays
          • DNA Assays
          • Electrophoresis
        • India Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
          • Dry Blood Spot Test
          • Critical Congenital Heart Disease (CCHD)
          • Hearing Screen
    • Latin America
      •  Brazil
        • Brazil Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
          • Instruments
          • Reagents & Assay Kits
        • Brazil Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
          • Tandem Mass Spectrometry
          • Pulse Oximetry
          • Enzyme Based Assays
          • DNA Assays
          • Electrophoresis
        • Brazil Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
          • Dry Blood Spot Test
          • Critical Congenital Heart Disease (CCHD)
          • Hearing Screen
      •  Mexico
        • Mexico Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
          • Instruments
          • Reagents & Assay Kits
        • Mexico Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
          • Tandem Mass Spectrometry
          • Pulse Oximetry
          • Enzyme Based Assays
          • DNA Assays
          • Electrophoresis
        • Mexico Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
          • Dry Blood Spot Test
          • Critical Congenital Heart Disease (CCHD)
          • Hearing Screen
    •  MEA
      • South Africa
        • South Africa Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
          • Instruments
          • Reagents & Assay Kits
        • South Africa Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
          • Tandem Mass Spectrometry
          • Pulse Oximetry
          • Enzyme Based Assays
          • DNA Assays
          • Electrophoresis
        • South Africa Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
          • Dry Blood Spot Test
          • Critical Congenital Heart Disease (CCHD)
          • Hearing Screen

Report Content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments 

Quantitative Analysis

  • Market size, estimates, and forecast from 2012 to 2022
  • Revenue estimates for product up to 2022
  • Regional market size and forecast for product up to 2022
  • Revenue estimates for technology up to 2022
  • Regional market size and forecast for technology up to 2022
  • Revenue estimates for test up to 2022
  • Regional market size and forecast for test up to 2022
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.